Andrea N. Edginton

5.1k total citations
140 papers, 3.8k citations indexed

About

Andrea N. Edginton is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Hematology. According to data from OpenAlex, Andrea N. Edginton has authored 140 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pediatrics, Perinatology and Child Health, 36 papers in Pharmacology and 31 papers in Hematology. Recurrent topics in Andrea N. Edginton's work include Pharmaceutical studies and practices (38 papers), Antibiotics Pharmacokinetics and Efficacy (30 papers) and Hemophilia Treatment and Research (29 papers). Andrea N. Edginton is often cited by papers focused on Pharmaceutical studies and practices (38 papers), Antibiotics Pharmacokinetics and Efficacy (30 papers) and Hemophilia Treatment and Research (29 papers). Andrea N. Edginton collaborates with scholars based in Canada, United States and Germany. Andrea N. Edginton's co-authors include Stefan Willmann, Walter Schmitt, Paul Malik, Alfonso Iorio, Alanna McEneny‐King, Jörg Lippert, Barbara Voith, Gary Foster, Gerald R. Stephenson and Herman J. Boermans and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Science & Technology and Blood.

In The Last Decade

Andrea N. Edginton

134 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea N. Edginton Canada 33 1.1k 830 778 534 507 140 3.8k
Carl C. Peck United States 32 589 0.5× 703 0.8× 370 0.5× 161 0.3× 496 1.0× 108 3.3k
Trevor N. Johnson United Kingdom 34 1.8k 1.5× 1.1k 1.4× 885 1.1× 70 0.1× 321 0.6× 85 3.6k
Anke H. Maitland‐van der Zee Netherlands 39 848 0.7× 1.9k 2.3× 438 0.6× 89 0.2× 1.0k 2.0× 295 6.6k
Masoud Jamei United Kingdom 45 1.4k 1.2× 2.1k 2.6× 901 1.2× 141 0.3× 1.0k 2.0× 133 6.1k
Vishal S. Vaidya United States 48 468 0.4× 631 0.8× 364 0.5× 245 0.5× 2.1k 4.2× 104 8.8k
Issam Zineh United States 32 536 0.5× 1.1k 1.3× 345 0.4× 74 0.1× 867 1.7× 132 4.6k
Thomas M. Ludden United States 32 766 0.7× 687 0.8× 612 0.8× 187 0.4× 505 1.0× 158 4.1k
Neil Parrott Switzerland 37 713 0.6× 1.5k 1.8× 573 0.7× 113 0.2× 1.0k 2.0× 125 4.5k
Jürgen Burhenne Germany 49 865 0.8× 1.3k 1.5× 978 1.3× 130 0.2× 1.3k 2.5× 236 6.5k
Hannah M. Jones United States 36 524 0.5× 1.4k 1.7× 319 0.4× 144 0.3× 1.1k 2.2× 105 3.8k

Countries citing papers authored by Andrea N. Edginton

Since Specialization
Citations

This map shows the geographic impact of Andrea N. Edginton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea N. Edginton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea N. Edginton more than expected).

Fields of papers citing papers by Andrea N. Edginton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea N. Edginton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea N. Edginton. The network helps show where Andrea N. Edginton may publish in the future.

Co-authorship network of co-authors of Andrea N. Edginton

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea N. Edginton. A scholar is included among the top collaborators of Andrea N. Edginton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea N. Edginton. Andrea N. Edginton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Edginton, Andrea N., et al.. (2025). A Hemophilia Joint Health Score-Based Model for the Economic Evaluation of Hemophilia A Prophylaxis Interventions. PharmacoEconomics. 43(7). 765–778.
2.
Najjar, Abdulkarim, et al.. (2024). Global sensitivity analysis of Open Systems Pharmacology Suite physiologically based pharmacokinetic models. CPT Pharmacometrics & Systems Pharmacology. 13(12). 2052–2067. 3 indexed citations
3.
Thompson, Elizabeth J., Angela Jeong, Valentina Shakhnovich, et al.. (2024). Physiologically‐based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population. CPT Pharmacometrics & Systems Pharmacology. 13(8). 1394–1408. 4 indexed citations
4.
Hamadeh, Abdullah, et al.. (2023). Mechanistic Skin Modeling of Plasma Concentrations of Sunscreen Active Ingredients Following Facial Application. Journal of Pharmaceutical Sciences. 113(3). 806–825. 7 indexed citations
5.
6.
Ford, Jennifer Lynn, Andrea N. Edginton, Eliana M. Perrin, et al.. (2022). Use of physiologically‐based pharmacokinetic modeling to inform dosing of the opioid analgesics fentanyl and methadone in children with obesity. CPT Pharmacometrics & Systems Pharmacology. 11(6). 778–791. 10 indexed citations
7.
Edginton, Andrea N., et al.. (2022). Antimicrobial Dosing Recommendations in Pediatric Continuous Renal Replacement Therapy: A Critical Appraisal of Current Evidence. Frontiers in Pediatrics. 10. 889958–889958. 8 indexed citations
8.
9.
Chelle, Pierre, et al.. (2021). External qualification of the Web‐Accessible Population Pharmacokinetic Service–Hemophilia (WAPPS‐Hemo) models for octocog alfa using real patient data. Research and Practice in Thrombosis and Haemostasis. 5(7). e12599–e12599. 3 indexed citations
10.
Salerno, Sara, Andrea N. Edginton, Matthew M. Laughon, et al.. (2020). Physiologically‐Based Pharmacokinetic Modeling Characterizes the CYP3A‐Mediated Drug‐Drug Interaction Between Fluconazole and Sildenafil in Infants. Clinical Pharmacology & Therapeutics. 109(1). 253–262. 31 indexed citations
11.
Malik, Paul, Shruti Nambiar, Pierre Chelle, et al.. (2019). Biodistribution and Physiologically-Based Pharmacokinetic Modeling of Gold Nanoparticles in Mice with Interspecies Extrapolation. Pharmaceutics. 11(4). 179–179. 42 indexed citations
12.
13.
Malik, Paul, Abdullah Hamadeh, Colin Phipps, & Andrea N. Edginton. (2017). Population PBPK modelling of trastuzumab: a framework for quantifying and predicting inter-individual variability. Journal of Pharmacokinetics and Pharmacodynamics. 44(3). 277–290. 25 indexed citations
14.
McEneny‐King, Alanna, Alfonso Iorio, Gary Foster, & Andrea N. Edginton. (2016). The use of pharmacokinetics in dose individualization of factor VIII in the treatment of hemophilia A. Expert Opinion on Drug Metabolism & Toxicology. 12(11). 1313–1321. 39 indexed citations
15.
Edginton, Andrea N., Eric I. Zimmerman, Aksana Vasilyeva, Sharyn D. Baker, & John C. Panetta. (2016). Sorafenib metabolism, transport, and enterohepatic recycling: physiologically based modeling and simulation in mice. Cancer Chemotherapy and Pharmacology. 77(5). 1039–1052. 43 indexed citations
16.
Wang, Jian, Andrea N. Edginton, Debbie Avant, & Gilbert J. Burckart. (2015). Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling. The Journal of Clinical Pharmacology. 55(10). 1175–1183. 16 indexed citations
17.
Angka, Leonard, Andrew Mitchell, Rose Hurren, et al.. (2015). Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death. Cancer Research. 75(12). 2478–2488. 134 indexed citations
18.
Edginton, Andrea N., et al.. (2011). Have physiologically-based pharmacokinetic models delivered?. Expert Opinion on Drug Metabolism & Toxicology. 7(8). 929–934. 9 indexed citations
19.
Szeitz, András, Andrea N. Edginton, Henry T. Peng, Bob Cheung, & K. Wayne Riggs. (2010). A Validated Enantioselective Assay for the Determination of Ibuprofen in Human Plasma Using Ultra Performance Liquid Chromatography with Tandem Mass Spectrometry (UPLC-MS/MS). American Journal of Analytical Chemistry. 1(2). 47–58. 32 indexed citations
20.
Edginton, Andrea N., Frank‐Peter Theil, Walter Schmitt, & Stefan Willmann. (2008). Whole body physiologically-based pharmacokinetic models: their use in clinical drug development. Expert Opinion on Drug Metabolism & Toxicology. 4(9). 1143–1152. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carl C. Peck Breakdown of academic impact, for papers by Trevor N. Johnson Breakdown of academic impact, for papers by Anke H. Maitland‐van der Zee Breakdown of academic impact, for papers by Masoud Jamei Breakdown of academic impact, for papers by Vishal S. Vaidya Breakdown of academic impact, for papers by Issam Zineh Breakdown of academic impact, for papers by Thomas M. Ludden Breakdown of academic impact, for papers by Neil Parrott Breakdown of academic impact, for papers by Jürgen Burhenne Breakdown of academic impact, for papers by Hannah M. Jones
Rankless by CCL
2026